Protagenic Therapeutics, Inc.\new Preferred Stock, Liquidation Preference, Value
Protagenic Therapeutics, Inc.\new (PTIX) had Preferred Stock, Liquidation Preference, Value of $20.70 billion as of 2015-12-31, per its 10-Q filed 2016-03-11.
Discontinued › Balance Sheet › Equity
us-gaap:PreferredStockLiquidationPreferenceValue · last filed 2016-03-11
- 2015-12-31: Preferred Stock, Liquidation Preference, Value $20.70B.
- 2015-09-30: Preferred Stock, Liquidation Preference, Value $20.70M.
- 2015-06-30: Preferred Stock, Liquidation Preference, Value $20.70M.
- 2015-03-31: Preferred Stock, Liquidation Preference, Value $20.70M.
| Period end | Preferred Stock, Liquidation Preference, Value |
|---|---|
| 2015-12-31 | $20.70B 10-Q · filed 2016-03-11 |
| 2015-09-30 | $20.70M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $20.70M 10-K · filed 2015-09-25 |
| 2015-03-31 | $20.70M 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |